Search for: "Precision Biosciences Inc." Results 21 - 33 of 33
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Dec 2010, 3:01 am by Kelly
Mayo (Holman’s Biotech IP Blog) (Patent Docs) (IPBiz) US: Anticancer files patent infringement suit against Cellsight over their fluorescence optical imaging service (Patent Docs) US: Precision BioSciences files for declaratory judgment of non-infringement of Cellectis patent in connection with its directed nuclease editor technology (Patent Docs) US: Former Professor fails to dismiss St. [read post]
19 Aug 2010, 3:00 am by Stefanie Levine
  The ‘691 patent is currently the subject of a litigation styled Pacific Bioscience Laboratories, Inc. v. [read post]
6 Aug 2013, 8:36 am by Lawrence B. Ebert
The doctrine of equivalents is premised on language's inability to capture the essence of innovation, but a prior application describing the precise element at issue undercuts that premise. [read post]
2 Dec 2018, 9:05 pm by Cookson Beecher
In California, Arcadia Biosciences inc. is also using gene-editing to develop consumer friendly foods. [read post]
23 Apr 2018, 1:20 am by Kevin LaCroix
Supreme Court issued its unanimous decision in Cyan, Inc. v. [read post]
15 Dec 2010, 2:17 am by Kelly
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not… [read post]
16 Sep 2009, 1:47 pm
(Allston, MA; Tae Yi, President) Black Trace, Inc. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
LeadCare® Test Kits have been recalled by Meridian Bioscience, Inc. due to a risk of inaccurate readings. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
22 Mar 2008, 2:00 am
: (Generic Pharmaceuticals & IP),EU: Counterfeit medicines in the EU: a new consultation: (Class 46)Thailand US Trade Representative to ‘talk’ to Thai government: (Generic Pharmaceuticals & IP), US: Cellectis SA files suit against Precision BioSciences, alleging infringement of two patents relating to materials used to make genome modifications in certain types of organisms: (IP Law360), US: PharmaBiotech IP Summit 28-30 May, Philadelphia will… [read post]